38226 Car-t prep t lymphcyt f/trns
Also known as: CAR-T manufacturing, T-cell modification
Preparation and genetic modification of T lymphocytes for chimeric antigen receptor T-cell therapy including transduction and expansion.
In Plain Language
Engineering immune cells for cancer
Clinical Context
Manufacturing phase of CAR-T therapy involving transduction of T cells with CAR construct and ex vivo expansion.
RVU Breakdown
| Work RVU | 0.77 |
| Total RVU | 0.77 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
As a surgical CPT code, proper documentation must include the operative report detailing the procedure performed, patient positioning, approach, findings, and any complications. Ensure the diagnosis code (ICD-10) supports medical necessity for the procedure.
How This Code Compares
With a work RVU of 0.77, this code ranks in the 3rd percentile among Surgery codes — 10.4x below the median (8.00). The highest wRVU in this category is 106.19.
Specialties
Frequently Asked Questions
What is CPT code 38226?
CPT 38226 (Car-t prep t lymphcyt f/trns) is a Surgery code. Preparation and genetic modification of T lymphocytes for chimeric antigen receptor T-cell therapy including transduction and expansion.
What is the wRVU value for CPT 38226?
The work RVU for CPT 38226 is 0.77. This code is primarily used by Hematology/Oncology, Immunotherapy, Cell Therapy.
When is CPT 38226 used?
Manufacturing phase of CAR-T therapy involving transduction of T cells with CAR construct and ex vivo expansion.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.